| Date | Name | Shares | Transaction | Value |
|
Jan 7, 2026
| Ryan D. Werner SVP, CAO |
872,026
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Jonathan Gibbs CDCO |
1,232,899
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Jonathan Gibbs CDCO |
759,341
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Jason Chung EVP, CORP DEV |
3,129,142
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Jason Chung EVP, CORP DEV |
2,655,584
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Stephen Howell COO |
2,030,734
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Stephen Howell COO |
1,636,102
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Stephen Howell COO |
1,438,786
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $12.67 per share |
18,229,418.62
|
|
Jan 7, 2026
| William Jackman CHIEF LEGAL OFFICER (CLO) |
2,853,105
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| William Jackman CHIEF LEGAL OFFICER (CLO) |
2,458,473
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Ryan D. Werner SVP, CAO |
990,414
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Ryan D. Werner SVP, CAO |
812,832
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $12.67 per share |
10,298,581.44
|
|
Jan 7, 2026
| Jason Les CEO; Director |
8,673,921
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Jason Les CEO; Director |
7,726,803
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Benjamin Yi EXECUTIVE CHAIRMAN; Director |
9,638,339
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Benjamin Yi EXECUTIVE CHAIRMAN; Director |
8,691,221
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Jan 7, 2026
| Colin M. Yee EVP, CFO |
2,115,366
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 6, 2025
| Hubert Romeo Marleau Director |
5,000
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $9.58 per share |
47,900.00
|
|
Feb 26, 2025
| Jaime Leverton Director |
12,000
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Feb 26, 2025
| Michael Turner Director |
12,000
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|